Olatec Therapeutics jobs and careers

New York, NY, United States

olatec.com LinkedIn @OlatecThera

About Olatec Therapeutics

Olatec is a privately held biopharmaceutical company developing a platform of safe, oral NLRP3 antagonist therapeutics, to treat and prevent a broad spectrum of acute and chronic inflammatory diseases that are known to be mediated by Interleukin-1 (IL-1), including: arthritis, heart failure, asthma, Alzheimer’s disease, multiple sclerosis, type-2 diabetes, melanoma and breast cancers, among others.

Founded in 2003 by Damaris Skouras and Richard Steadman.

Pharmaceutical Biopharma Biotechnology Health Care

Founded: 2003
Employees: 1 to 10
Total funding: $102.3M
Headquarters: New York

Leadership

The top of Olatec Therapeutics's org chart, with how many people report into each leader.

DS

Damaris B. Skouras

Founder, Chairman & CEO

5 reports

SH

Sophia Hughes

Investor Relations, Public Relations & Communications

PP

Piscitelli Philip

Vice President, Clinical Development Operations

JC

Jeanette Rooney, CPA, CGMA

Vice President Finance & Treasurer

CB

Cynthia (Dana) Barrow

VP Compliance And Risk

CD

Charles A. Dinarello

Chairman, SAB & co-Chief Scientific Officer

Board

RD

Robert H. Dworkin

Scientific Advisor

SN

Steven B. Newhard

Scientific Advisor

SG

Shayne C. Gad

Scientific Advisor

LJ

Leo A. B. Joosten

Scientific Advisor

HM

Howard I. Maibach

Scientific Advisor

AM

Alberto Mantovani

Scientific Advisor

Jobs at Olatec Therapeutics

No open positions right now. Explore more companies on TheJobsMap.